Biotechnology Jobs

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of medical directors and clinical scientists designing and executing early-phase oncology trials, including first-in-human and proof-of-concept studies, while bridging preclinical discovery and clinical development. Accountable for clinical development plans, translational and biomarker strategy, and regulatory submissions across lung and head/neck cancer programmes.

AI/ML · Real World Evidence

• London
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Senior · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability and chairing a cross-functional matrix Medicine Development Team spanning clinical, translational, regulatory, manufacturing and commercial. Drives strategy, go/no-go decisions and lifecycle plans for novel vaccine platforms such as mRNA and neoantigen-based therapies.

mRNA · Checkpoint Inhibitors

• Waltham, United States
• On-site
• US$150,975 – US$251,625 pa
• Mid-level

Key member of the Clinical Development team contributing to the design, execution, analysis and reporting of clinical studies across all phases. Works cross-functionally with Medical Monitoring, Clinical Operations, Biostatistics, Data Management and Regulatory Affairs, reviewing safety, efficacy, biomarker and PK/PD data and supporting CSRs and regulatory submissions. Based on-site in Waltham, MA or London, UK.

• London
• On-site

Contributes to the design, execution, analysis and reporting of hepatology clinical studies across all development phases, working with clinical operations, biostatistics, data management and regulatory affairs. Reviews safety, efficacy, biomarker and PK/PD data, supports protocol and CSR development, and engages with investigators and sites. Based on-site in London or Waltham, MA.

• Stevenage
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining predictive biomarkers, patient segmentation and go/no-go decision criteria. Represents Translational Medicine on Clinical Matrix Teams and works across diagnostics, data sciences and external partners to validate assays and deliver biomarker data packages.

NGS · FISH · PCR +5

• Grimsby
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

IHC/IF · Liquid Biopsy · ctDNA +3

• Baar Onyx
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, FISH, PCR, IHC/IF, flow cytometry, liquid biopsy/ctDNA and multi-omic analyses, and oversees sample testing plans and biomarker data packages for clinical and regulatory decisions.

NGS · FISH · PCR +6

• USA - Pennsylvania - Upper Providence
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, ctDNA, flow cytometry and multi-omic analyses to inform dose selection and go/no-go decisions.

IHC/IF · Liquid Biopsy · ctDNA +3

• London
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

IHC/IF · Liquid Biopsy · ctDNA +3

• Stevenage
• Hybrid
• Director

Senior individual-contributor role building a cardiovascular and cardiometabolic translational biology strategy within a respiratory and immunology research unit. Involves evaluating targets, defining human-relevant mechanistic hypotheses, biomarker strategies, multi-omics and reverse translation, plus business development diligence and external academic partnerships across a matrixed organisation.

• USA - Pennsylvania - Upper Providence
• Hybrid
• Director

Senior individual-contributor role building a cardiovascular and cardiometabolic translational biology strategy within a respiratory and immunology research unit. Involves defining human-relevant mechanistic hypotheses, biomarker strategies, target evaluation, and business development diligence, with matrix influence across clinical, genetics, and portfolio teams.

• London
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety data review and scientific oversight of protocols and analysis plans. Collaborates with cross-functional teams, investigators and thought leaders, and presents results for publications and regulatory submissions. Hybrid role with two to three days per week in office.

Digital Tools

• Waltham, United States
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety data review and scientific oversight of protocols and analysis plans. Collaborates with cross-functional teams, investigators and thought leaders, and presents results for publications and regulatory submissions. Hybrid role with two to three days per week in office.

• USA - Pennsylvania - Upper Providence
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety oversight and scientific interpretation of protocols and analysis plans. Collaborates with cross-functional teams, investigators and regulators, and presents results for publications and submissions. Hybrid role with two to three days per week in office.

• Stevenage
• Director

Leads Quantitative Systems Pharmacology and QST modelling within GSK's Clinical Pharmacology and Quantitative Medicine group, building mechanistic mathematical models of disease, drug action and trial design. Defines clinical pharmacology strategy across the Respiratory, Immunology and Inflammation portfolio, working with biologists, clinicians, statisticians and AI/ML colleagues. The role sits in a newly formed Centre of Excellence for Model-Informed Drug Development, initially in Stevenage with a planned move to Cambridge.